UBS Group Forecasts Strong Price Appreciation for Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK) Stock

Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK) had its price objective hoisted by equities researchers at UBS Group from $71.00 to $74.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the stock. UBS Group‘s price target indicates a potential upside of 12.50% from the company’s current price.

A number of other equities research analysts also recently weighed in on the company. Mizuho raised Vivmark Residential Common Shares of Beneficial Interest from a “neutral” rating to an “outperform” rating and lifted their target price for the stock from $70.00 to $73.00 in a report on Tuesday, September 8th. Cantor Fitzgerald decreased their price target on Vivmark Residential Common Shares of Beneficial Interest from $70.00 to $68.00 and set a “neutral” rating on the stock in a research note on Monday. Wells Fargo & Company lowered their price objective on shares of Vivmark Residential Common Shares of Beneficial Interest from $72.00 to $68.00 and set an “overweight” rating for the company in a research report on Monday, October 19th. BTIG Research reaffirmed a “neutral” rating on shares of Vivmark Residential Common Shares of Beneficial Interest in a research note on Thursday, September 17th. Finally, Evercore initiated coverage on Vivmark Residential Common Shares of Beneficial Interest in a research report on Tuesday, August 18th. They set an “in-line” rating and a $72.00 target price on the stock. Five analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $71.42.

Vivmark Residential Common Shares of Beneficial Interest Trading Down 0.5%

Shares of Vivmark Residential Common Shares of Beneficial Interest stock traded down $0.36 during trading on Tuesday, hitting $65.78. 6,107,450 shares of the stock were exchanged, compared to its average volume of 3,660,934. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.19 and a quick ratio of 0.19. The stock has a fifty day moving average of $62.61. The firm has a market cap of $24.66 billion, a PE ratio of 243.63, a price-to-earnings-growth ratio of 3.69 and a beta of 0.72. Vivmark Residential Common Shares of Beneficial Interest has a 1-year low of $57.57 and a 1-year high of $71.50.

Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK) last issued its earnings results on Wednesday, July 22nd. The company reported $0.30 EPS for the quarter. Vivmark Residential Common Shares of Beneficial Interest had a return on equity of 8.06% and a net margin of 27.97%. The company had revenue of $785.05 million during the quarter. Equities research analysts forecast that Vivmark Residential Common Shares of Beneficial Interest will post 4.08 EPS for the current fiscal year.

Insider Activity at Vivmark Residential Common Shares of Beneficial Interest

In other news, Director Susan Swanezy sold 15,700 shares of the firm’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $63.80, for a total value of $1,001,660.00. Following the completion of the transaction, the director directly owned 28,934 shares in the company, valued at approximately $1,845,989.20. This trade represents a 35.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Michael L. Manelis sold 7,825 shares of the company’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $64.31, for a total value of $503,225.75. Following the completion of the transaction, the chief operating officer owned 44,713 shares in the company, valued at $2,875,493.03. This represents a 14.89% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 58,286 shares of company stock worth $3,735,822 in the last three months. Corporate insiders own 1.20% of the company’s stock.

Institutional Trading of Vivmark Residential Common Shares of Beneficial Interest

Several hedge funds and other institutional investors have recently bought and sold shares of VMRK. Blume Capital Management Inc. bought a new position in shares of Vivmark Residential Common Shares of Beneficial Interest during the third quarter valued at about $25,000. Physician Wealth Advisors Inc. bought a new stake in shares of Vivmark Residential Common Shares of Beneficial Interest in the 3rd quarter worth approximately $27,000. Farmers & Merchants Investments Inc. purchased a new stake in Vivmark Residential Common Shares of Beneficial Interest during the 3rd quarter valued at about $31,000. Planning Strategies Inc. raised its stake in shares of Vivmark Residential Common Shares of Beneficial Interest by 87.5% in the third quarter. Planning Strategies Inc. now owns 538 shares of the company’s stock worth $33,000 after purchasing an additional 251 shares during the last quarter. Finally, Mather Group LLC. bought a new position in Vivmark Residential Common Shares of Beneficial Interest during the third quarter valued at approximately $33,000. Hedge funds and other institutional investors own 92.68% of the company’s stock.

Vivmark Residential Common Shares of Beneficial Interest Company Profile

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.